Edgewise Therapeutics (EWTX) Insider Trading & Ownership $14.35 -0.30 (-2.05%) Closing price 08/29/2025 04:00 PM EasternExtended Trading$14.36 +0.01 (+0.07%) As of 08/29/2025 06:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Edgewise Therapeutics (NASDAQ:EWTX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage23.20%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$10.00MNumber OfInsiders Selling(Last 12 Months)6Amount OfInsider Selling(Last 12 Months)$14.41M Get EWTX Insider Trade Alerts Want to know when executives and insiders are buying or selling Edgewise Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. EWTX Insider Buying and Selling by Quarter Edgewise Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails8/26/2025Alan J RussellInsiderSell100,000$14.60$1,460,000.00 8/12/2025Alan J RussellInsiderSell1,907$13.39$25,534.73 8/12/2025Joanne M DonovanCMOSell2,862$13.39$38,322.18 8/12/2025John R MooreGeneral CounselSell2,098$13.39$28,092.22 8/12/2025Kevin KochCEOSell7,972$13.39$106,745.08 8/12/2025R Michael CarruthersCFOSell1,428$13.39$19,120.92 5/2/2025Alan J RussellInsiderSell1,551$16.45$25,513.95 5/2/2025Joanne M DonovanCMOSell5,187$16.45$85,326.15 5/2/2025John R MooreGeneral CounselSell1,930$16.45$31,748.50 5/2/2025Kevin KochCEOSell4,276$16.45$70,340.20 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 5/2/2025R Michael CarruthersCFOSell1,314$16.45$21,615.30 4/3/2025Orbimed Advisors LlcDirectorBuy496,771$20.13$10,000,000.23 2/6/2025Alan J RussellInsiderSell1,200$30.13$36,156.00 2/5/2025Kevin KochCEOSell8,636$30.03$259,339.08 1/28/2025Joanne M DonovanCMOSell25,000$27.63$690,750.00 12/30/2024Alan J RussellInsiderSell100,000$27.37$2,737,000.00 12/24/2024Marc SemigranInsiderSell29,709$29.69$882,060.21 9/23/2024John R MooreGeneral CounselSell20,922$27.63$578,074.86 9/20/2024Alan J RussellInsiderSell75,000$28.27$2,120,250.00 9/20/2024Joanne M DonovanCMOSell7,162$28.29$202,612.98 9/20/2024John R MooreGeneral CounselSell50,000$28.37$1,418,500.00 9/20/2024R Michael CarruthersCFOSell125,092$28.57$3,573,878.44 (Data available from 1/1/2013 forward) EWTX Insider Trading Activity - Frequently Asked Questions Who is on Edgewise Therapeutics' Insider Roster? The list of insiders at Edgewise Therapeutics includes Alan J Russell, Behrad Derakhshan, Holdings A/S Novo, Joanne M Donovan, John R Moore, Jonathan C Fox, Kevin Koch, Marc Semigran, Orbimed Advisors Llc, Peter A Thompson, and R Michael Carruthers. Learn more on insiders at EWTX. What percentage of Edgewise Therapeutics stock is owned by insiders? 23.20% of Edgewise Therapeutics stock is owned by insiders. Learn more on EWTX's insider holdings. Which Edgewise Therapeutics insiders have been buying company stock? The following insiders have purchased EWTX shares in the last 24 months: Jonathan C Fox ($100,970.10), Orbimed Advisors Llc ($10,000,000.23), and Peter A Thompson ($4,999,995.00). How much insider buying is happening at Edgewise Therapeutics? Insiders have purchased a total of 962,173 EWTX shares in the last 24 months for a total of $15,100,965.33 bought. Which Edgewise Therapeutics insiders have been selling company stock? The following insiders have sold EWTX shares in the last 24 months: Alan J Russell ($8,014,672.73), Behrad Derakhshan ($124,533.38), Joanne M Donovan ($1,086,637.93), John R Moore ($2,093,403.54), Kevin Koch ($496,028.68), Marc Semigran ($882,060.21), and R Michael Carruthers ($5,075,603.53). How much insider selling is happening at Edgewise Therapeutics? Insiders have sold a total of 887,615 Edgewise Therapeutics shares in the last 24 months for a total of $18,382,678.79 sold. Edgewise Therapeutics Key ExecutivesDr. Peter A. Thompson FACP (Age 64)M.D., Co-Founder & Independent Chairman Compensation: $76kDr. Kevin Koch Ph.D. (Age 64)President, CEO & Director Compensation: $905.52kDr. Badreddin Edris Ph.D. (Age 37)Co-Founder & Independent Director Compensation: $43kDr. Behrad Derakhshan Ph.D. (Age 44)Chief Business Officer Compensation: $630.67kDr. Joanne M. Donovan M.D. (Age 67)Ph.D., Chief Medical Officer Compensation: $696.4kDr. Alan J. Russell Ph.D. (Age 54)Co-Founder, Chief Scientific Officer & Director Compensation: $657.52kMr. R. Michael Carruthers (Age 66)Chief Financial Officer Compensation: $386.01k2 recent tradesMr. John R. Moore (Age 60)General Counsel 2 recent tradesDr. Marc Semigran M.D. (Age 67)Chief Development Officer More Insider Trading Tools from MarketBeat Related Companies RNA Insider Ownership AXSM Insider Ownership NUVL Insider Ownership MRUS Insider Ownership CRSP Insider Ownership TGTX Insider Ownership CYTK Insider Ownership KRYS Insider Ownership ACAD Insider Ownership ADMA Insider Ownership Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Costco Faces Downgrades, Death Cross, Insider SellingReynolds Consumer Products Stock Price: Insiders Signal a BottomBuy, Sell, or Hold? Insiders Pile Into These 3 Healthcare StocksInsiders Trade Millions in NVIDIA-Linked Navitas, Hims, & Shift45 Stocks Insiders Are Selling That Analysts Say Buy This page (NASDAQ:EWTX) was last updated on 8/30/2025 by MarketBeat.com Staff From Our PartnersBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored“HELIOS”: My No. 1 Investment of the 2020sA mysterious new energy technology — backed by Nvidia, Google, and even legendary investors like Stanley Druck...Stansberry Research | SponsoredHow “Trump’s New Dollar” Could Impact Your WealthPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | SponsoredFree: The Crypto Summit That Could Change Your Life27 industry leaders share urgent market intel (free access)... For a very limited time, you can claim your ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Edgewise Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Edgewise Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
